发明名称 Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds
摘要 The present invention relates to a haemodialysis solution or concentrate thereof comprising creatine compound(s) and the use of creatine compound(s) for preparing a dialysis solution or concentrate thereof. Furthermore, the present invention is directed to a method for preparing creatine-containing dialysis solutions and concentrates. In addition, the present invention is directed to a method for treating patients with dialysis dependent renal failure with creatine compounds and to provide a variety of significant health benefits and improvement of life quality parameters for dialysis patients. This is achieve by supporting and improving the physiological functions of the patients organs and cells via creatine compounds delivery to the patients, and by protecting organs and cells (specifically including blood cells) of these patients from deleterious effects of a variety of endogenous or exogenous cellular stressors that are linked to the disease state or to the clinical treatment modalities. Furthermore in peritoneal dialysis solutions creatine can be used as an osmotic agent preventing side effects caused by high glucose supplementation.
申请公布号 US9248112(B2) 申请公布日期 2016.02.02
申请号 US201013263189 申请日期 2010.03.10
申请人 CREARENE LTD. 发明人 Möddel Michael;Wallimann Theo
分类号 A01N57/00;A61K31/66;A01N37/44;A61K31/195;A61K31/198;A61K9/00;A61K9/08;A61K47/02;A61K47/26 主分类号 A01N57/00
代理机构 Rankin, Hill & Clark LLP 代理人 Rankin, Hill & Clark LLP
主权项 1. A hemodialysis or peritoneal dialysis solution comprising one or more compounds selected from the group consisting of: (i) creatine; (ii) (phospho)creatine; (iii) (phospho)cyclocreatine; (iv) homocyclocreatine; (v) (phospho)creatine monohydrate; (vi) guanidinoacetic acid; (vii) 3-guanidinopropionic acid; (viii) guanidino benzoic acid; (ix) a combination of glycine, arginine and methionine; and (x) a physiologically acceptable salt of any of (i) through (ix); wherein said one or more compounds are present in the hemodialysis or peritoneal dialysis solution at a concentration equivalent to from 0.002 to 45 mM creatine, wherein the hemodialysis or peritoneal dialysis solution further comprises physiologically acceptable concentrations of sodium and chloride ions, and at least one physiologically acceptable buffering substance, and wherein the hemodialysis or peritoneal dialysis solution does not contain concentrations of any substances that would make the hemodialysis or peritoneal dialysis solution physiologically unacceptable.
地址 Nassau BS